Ryan Specialty Holdings Inc. RYAN
37.89
1.15
3.13%
as of 25 Sep
- Market cap
- $9.4B
- P/E
- 49.2×
Follow RYAN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
104.37 | 105.37 | 39.69 | 49.04 |
P/S ratio |
2.43 | 2.15 | 1.38 | 1.47 | |
P/FCF ratio |
12.67 | 11.47 | 7.90 | 9.60 | |
P/Operating CF |
42.50 | 24.96 | (26.07) | 16.14 | |
P/B ratio |
5.85 | 5.24 | 3.58 | 4.66 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.53 | 3.20 | 2.46 | 2.56 | |
EV/EBITDA |
12.98 | 12.24 | 9.82 | 10.60 | |
EV/Operating CF |
16.32 | 15.17 | 12.57 | 14.72 | |
EV/FCF |
18.36 | 17.05 | 14.09 | 16.69 | |
Quick Ratio |
0.13 | 0.12 | 0.13 | 0.13 | |
Current Ratio |
1.00 | 0.98 | 1.02 | 1.00 | |
Net Debt/EBITDA |
17.16 | 18.87 | 20.52 | 13.90 | |
Debt/Assets |
34.42% | 31.73% | 32.41% | 30.36% | |
Debt/Equity |
2.75 | 2.67 | 2.93 | 3.58 | |
Asset Turnover |
0.32 | 0.30 | 0.30 | 0.28 | |
Operating CF/Net income |
5.46 | 32.99 | (9.49) | 6.92 | |
Capex/Depreciation |
(0.21) | (0.22) | (0.18) | (0.26) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
73.95% | 75.90% | 75.95% | 70.94% | |
Intangible Assets out of Total Assets |
0.33 | 0.32 | 0.30 | 0.28 | |
Share Based Compensation of Revenue |
6.76% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.58) | (0.65) | (0.97) | (0.91) | |
Graham Number |
10.82 | 10.42 | 13.42 | 11.85 | |
Earnings Yield |
0.96% | 0.95% | 2.52% | 2.04% | |
Free Cash Flow Yield |
7.89% | 8.72% | 12.65% | 10.42% | |
Revenue per Share |
5.90 | 5.90 | 6.15 | 7.32 | |
Operating CF per Share |
1.33 | 2.07 | (1.29) | 2.34 | |
Capex per Share |
(0.13) | (0.14) | (0.10) | (0.15) | |
Free Cash Flow per Share |
1.20 | 1.93 | (1.40) | 2.19 | |
Cash per Share |
1.20 | 1.24 | 1.20 | 1.12 | |
Shareholders Equity per Share |
9.63 | 9.85 | 9.42 | 8.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.63 | 9.85 | 9.42 | 8.11 | |
Free Cash Flow |
153.18 | 245.97 | (180.68) | 274.31 | |
Working Capital |
(10.06) | (128.57) | 122.87 | (13.03) | |
Capital Expenditures |
(16.48) | (17.27) | (13.26) | (18.72) | |
Net Current Asset Value |
(4,173.15) | (4,249.94) | (4,213.76) | (4,307.92) | |
EV/EBIT |
20.43 | 19.78 | 15.94 | 17.23 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
4.12% | 1.06% | 2.22% | 4.62% | |
Price to Operating Income |
14.10 | 13.31 | 8.95 | 9.91 | |
| Other line items | |||||
Average Receivables |
387.22 | 439.35 | 498.87 | 613.06 | |
Average Payables |
231.84 | 266.80 | 269.46 | 268.25 | |
Average Assets |
9,165.18 | 10,107.04 | 10,450.84 | 11,296.20 | |
Average Common Equity |
1,166.70 | 1,176.17 | 1,138.18 | 1,099.15 |
Columns are period end dates